Tag: digital pathology

2019 Outlook: Lab Industry Future Looks Dire, From Reactions to Recent Medicare Fraud Cases to PAMA Reporting and Other Stress Factors

By Mary Van Doren, from the Volume XXV No. 18 – December 24, 2018 issue

CEO SUMMARY: This year’s list of the Top 10 Lab Industry Stories for 2018 is dominated by new directives from Medicare and private health insurers, as well as significant decisions by federal courts. Collectively, these developments create new compliance risks for all clinical laboratories and anatomic pathology groups. What is more notable about these top

View Article

UK’s NHS to Build Five New Digital Path and Imaging Centers

By Joseph Burns, from the Volume XXV No. 18 – December 24, 2018 issue

TO SHORTEN THE TIME FOR CANCER DIAGNOSES, the United Kingdom’s National Health Service (NHS) will open five new digital pathology and imaging centers that will use artificial intelligence. The digital pathology and imaging centers will open in Coventry, Glasgow, Leeds, London, and Oxford.

Last month, the UK government announced that it will invest £50 million ($68.9

View Article

Several Big Surprises in 2018’s Top 10 Lab Stories

By Robert Michel, from the Volume XXV No. 18 – December 24, 2018 issue

View Article

GE Healthcare Sells Omnyx to Inspirata

By Joseph Burns, from the Volume XXV No. 3 – February 12, 2018 issue

CEO SUMMARY: Now that the FDA has cleared a digital pathology for use in primary diagnosis, interest in DP is building. Inspirata purchased Omnyx and its assets because the Omnyx Dynamyx digital pathology software has strong features that could be integrated into Inspirata’s digital pathology solution. In this interview with THE DARK REPORT, Inspirata CEO

View Article

December 11, 2017 Intelligence: Late Breaking Lab News

By Robert Michel, from the Volume XXIV, No. 17 – December 11, 2017 issue

To deal with a shortage of surgical pathologists in the United Kingdom, the British National Health Service (NHS) is looking at solutions, such as deployment of digital pathology systems. According to a story in Pharma Times, the NHS is negotiating with Roche Diagnostics and partners to develop a program to implement digital pathology systems across the

View Article

Digital Pathology Systems Will Create Opportunities

By judeb, from the Volume XXIV, No. 7 – May 15, 2017 issue

CEO SUMMARY: Advanced Pathology Associates, a 15-member private pathology group practice, had the distinction of generating data for the clinical study that Philips submitted to the Food and Drug Administration for review of its whole slide imaging system. Following the FDA’s decision to clear this system for sale earlier this month, and informed by their

View Article

USC’s Clive Taylor, MD, Talks Digital Path, WSI

By Joseph Burns, from the Volume XXIV, No. 10 – July 17, 2017 issue

CEO SUMMARY: The FDA’s clearance of the first digital pathology system for use in primary diagnosis will be a disruptive force for pathologists in the coming years. At the University of Southern California Keck School of Medicine, pathologist Clive Taylor, MD, predicts that the benefits of whole slide imaging and digital pathology will enable pathologists

View Article

Digital Pathology Can Be Transformative for Labs

By Joseph Burns, from the Volume XXIV, No. 9 – June 26, 2017 issue

CEO SUMMARY: Across the nation, pathologists are at a crossroads. Now that the FDA has cleared a digital pathology and whole slide imaging (WSI) system for use in primary diagnosis, should they adopt this technology sooner or wait until later? One pathologist who has worked with WSI for many years shared the lessons learned in

View Article

Volume XXVI No. 2 – February 4, 2019

NOW THAT MOST HOSPITALS ARE INCLUDED as applicable laboratories that must report their PAMA private payer lab test price data to the Centers for Medicare and Medicaid Services, managers of those labs will benefit from the incisive analysis in this issue of the lessons learned during the 2017 PAMA reporting cycle. THE DARK REPORT further offers recommendations on how labs can do a better job of gathering and reporting their own data to CMS. Also, TDR delivers an exclusive analysis of why the Government Accounting Office's assertion that CMS will be paying billions more for Part B clinical lab tests is simply wrong.

See the full table of contents

Reliable Business Intelligence News About Clinical Laboratories, Pathology Groups, & Laboratory Diagnostics Since 1995

Tag: digital pathology

2019 Outlook: Lab Industry Future Looks Dire, From Reactions to Recent Medicare Fraud Cases to PAMA Reporting and Other Stress Factors

UK’s NHS to Build Five New Digital Path and Imaging Centers

Several Big Surprises in 2018’s Top 10 Lab Stories

GE Healthcare Sells Omnyx to Inspirata

December 11, 2017 Intelligence: Late Breaking Lab News

TOP 10 LAB STORIES OF 2017

Top 10 Lab Stories of 2017 Dominated by Part B Cuts

Digital Pathology Systems Will Create Opportunities

USC’s Clive Taylor, MD, Talks Digital Path, WSI

Digital Pathology Can Be Transformative for Labs

Tag: digital pathology

Enter Your Login Credentials